Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study. | Available online http content 9 5 R490 Research Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study Anne-Cornélie JM de Pont1 Kamran Bakhtiari2 Barbara A Hutten3 Evert de Jonge1 Margreeth B Vroom4 Joost CM Meijers5 Harry R Buller6 and Marcel Levi7 Intensivist Department of Intensive Care Academic Medical Center University of Amsterdam The Netherlands 2Laboratory Researcher Department of Vascular Medicine Academic Medical Center University of Amsterdam The Netherlands 3Clinical Epidemiologist Department of Epidemiology and Biostatistics Academic Medical Center University of Amsterdam The Netherlands 4Professor of Intensive Care Medicine Department of Intensive Care Academic Medical Center University of Amsterdam The Netherlands 5Head of the Laboratory of Vascular Medicine Department of Vascular Medicine Academic Medical Center University of Amsterdam The Netherlands 6Professor of Vascular Medicine Department of Vascular Medicine Academic Medical Center University of Amsterdam The Netherlands 7Professor of Internal Medicine Department of Internal Medicine Academic Medical Center University of Amsterdam The Netherlands Corresponding author Anne-Cornélie JM de Pont Received 24 Apr 2005 Revisions requested 3 Jun 2005 Revisions received 24 Jun 2005 Accepted 28 Jun 2005 Published 21 Jul 2005 Critical Care 2005 9 R490-R497 DOI 86 cc3774 This article is online at http content 9 5 R490 2005 de Pont et al. licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Open Access Abstract Introduction Recombinant human activated protein C rhAPC is the first drug for which a reduction of mortality in severe sepsis has been .
